HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Infectious Disease
RCT
Cefepime-nacubactam and aztreonam-nacubactam non-inferior for complicated UTI and pyelonephritis
New antibiotics show promise for complicated urinary tract infections
This phase 3 randomised double-blind study in adults with complicated urinary tract infection or acute uncomplicated pyelonephritis found ce…
A large trial found new antibiotic combinations worked better than standard care for certain urinary infections in adults.
May 16, 2026
Pediatrics
Meta-analysis
Systematic review and meta-analysis compares piperacillin-tazobactam and cefepime in pediatric febrile neutropenia
Two Antibiotics for Fever in Kids: One Works a Day Faster
This systematic review and meta-analysis evaluates piperacillin-tazobactam versus cefepime monotherapy in 470 episodes of pediatric febrile …
When a child on chemotherapy gets a fever, doctors have two main antibiotic choices, and a new analysis of 470 cases shows they work equally…
May 7, 2026
Infectious Disease
FDA Approval
FDA Approves Cefepime for Injection and Dextrose Injection (cefepime) for Moderate to Severe Pneumonia and Other Infections
The FDA approved a new ready-to-use version of an antibiotic called cefepime for serious infections
The FDA approved cefepime in a dextrose injection formulation for intravenous treatment of moderate to severe pneumonia, febrile neutropenia…
The FDA approved a ready-to-use antibiotic for serious infections like pneumonia and urinary tract infections in hospitalized patients.
FDA
Apr 10, 2026